124 related articles for article (PubMed ID: 10691697)
1. Structure-activity relationship studies on 1-[2-(4-Phenylphenoxy)ethyl]pyrrolidine (SC-22716), a potent inhibitor of leukotriene A(4) (LTA(4)) hydrolase.
Penning TD; Chandrakumar NS; Chen BB; Chen HY; Desai BN; Djuric SW; Docter SH; Gasiecki AF; Haack RA; Miyashiro JM; Russell MA; Yu SS; Corley DG; Durley RC; Kilpatrick BF; Parnas BL; Askonas LJ; Gierse JK; Harding EI; Highkin MK; Kachur JF; Kim SH; Krivi GG; Villani-Price D; Pyla EY; Smith WG
J Med Chem; 2000 Feb; 43(4):721-35. PubMed ID: 10691697
[TBL] [Abstract][Full Text] [Related]
2. Synthesis of potent leukotriene A(4) hydrolase inhibitors. Identification of 3-[methyl[3-[4-(phenylmethyl)phenoxy]propyl]amino]propanoic acid.
Penning TD; Russell MA; Chen BB; Chen HY; Liang CD; Mahoney MW; Malecha JW; Miyashiro JM; Yu SS; Askonas LJ; Gierse JK; Harding EI; Highkin MK; Kachur JF; Kim SH; Villani-Price D; Pyla EY; Ghoreishi-Haack NS; Smith WG
J Med Chem; 2002 Aug; 45(16):3482-90. PubMed ID: 12139459
[TBL] [Abstract][Full Text] [Related]
3. Pyrrolidine and piperidine analogues of SC-57461A as potent, orally active inhibitors of leukotriene A(4) hydrolase.
Penning TD; Chandrakumar NS; Desai BN; Djuric SW; Gasiecki AF; Liang CD; Miyashiro JM; Russell MA; Askonas LJ; Gierse JK; Harding EI; Highkin MK; Kachur JF; Kim SH; Villani-Price D; Pyla EY; Ghoreishi-Haack NS; Smith WG
Bioorg Med Chem Lett; 2002 Dec; 12(23):3383-6. PubMed ID: 12419366
[TBL] [Abstract][Full Text] [Related]
4. Pharmacological characterization of SC-57461A (3-[methyl[3-[4-(phenylmethyl)phenoxy]propyl]amino]propanoic acid HCl), a potent and selective inhibitor of leukotriene A(4) hydrolase I: in vitro studies.
Askonas LJ; Kachur JF; Villani-Price D; Liang CD; Russell MA; Smith WG
J Pharmacol Exp Ther; 2002 Feb; 300(2):577-82. PubMed ID: 11805219
[TBL] [Abstract][Full Text] [Related]
5. Pharmacological characterization of SC-57461A (3-[methyl[3-[4-(phenylmethyl)phenoxy]propyl]amino]propanoic acid HCl), a potent and selective inhibitor of leukotriene A(4) hydrolase II: in vivo studies.
Kachur JF; Askonas LJ; Villani-Price D; Ghoreishi-Haack N; Won-Kim S; Liang CD; Russell MA; Smith WG
J Pharmacol Exp Ther; 2002 Feb; 300(2):583-7. PubMed ID: 11805220
[TBL] [Abstract][Full Text] [Related]
6. Anti-inflammatory activity of a potent, selective leukotriene A4 hydrolase inhibitor in comparison with the 5-lipoxygenase inhibitor zileuton.
Rao NL; Dunford PJ; Xue X; Jiang X; Lundeen KA; Coles F; Riley JP; Williams KN; Grice CA; Edwards JP; Karlsson L; Fourie AM
J Pharmacol Exp Ther; 2007 Jun; 321(3):1154-60. PubMed ID: 17371808
[TBL] [Abstract][Full Text] [Related]
7. Identification of a potent, selective, and orally active leukotriene a4 hydrolase inhibitor with anti-inflammatory activity.
Grice CA; Tays KL; Savall BM; Wei J; Butler CR; Axe FU; Bembenek SD; Fourie AM; Dunford PJ; Lundeen K; Coles F; Xue X; Riley JP; Williams KN; Karlsson L; Edwards JP
J Med Chem; 2008 Jul; 51(14):4150-69. PubMed ID: 18588282
[TBL] [Abstract][Full Text] [Related]
8. Overview of recent drug discovery approaches for new generation leukotriene A4 hydrolase inhibitors.
Calışkan B; Banoglu E
Expert Opin Drug Discov; 2013 Jan; 8(1):49-63. PubMed ID: 23095029
[TBL] [Abstract][Full Text] [Related]
9. Identification of benzofuran central cores for the inhibition of leukotriene A(4) hydrolase.
Eccles W; Blevitt JM; Booker JN; Chrovian CC; Crawford S; de Leon AR; Deng X; Fourie AM; Grice CA; Herman K; Karlsson L; Kearney AM; Lee-Dutra A; Liang J; Luna R; Pippel D; Rao N; Riley JP; Santillán A; Savall B; Tanis VM; Xue X; Young AL
Bioorg Med Chem Lett; 2013 Feb; 23(3):811-5. PubMed ID: 23260350
[TBL] [Abstract][Full Text] [Related]
10. Attenuation of inflammation and cytokine production in rat colitis by a novel selective inhibitor of leukotriene A4 hydrolase.
Whittle BJ; Varga C; Berko A; Horvath K; Posa A; Riley JP; Lundeen KA; Fourie AM; Dunford PJ
Br J Pharmacol; 2008 Mar; 153(5):983-91. PubMed ID: 18157165
[TBL] [Abstract][Full Text] [Related]
11. Synthesis of glutamic acid analogs as potent inhibitors of leukotriene A4 hydrolase.
Kirkland TA; Adler M; Bauman JG; Chen M; Haeggström JZ; King B; Kochanny MJ; Liang AM; Mendoza L; Phillips GB; Thunnissen M; Trinh L; Whitlow M; Ye B; Ye H; Parkinson J; Guilford WJ
Bioorg Med Chem; 2008 May; 16(9):4963-83. PubMed ID: 18394906
[TBL] [Abstract][Full Text] [Related]
12. Synthesis of imidazopyridines and purines as potent inhibitors of leukotriene A4 hydrolase.
Penning TD; Chandrakumar NS; Desai BN; Djuric SW; Gasiecki AF; Malecha JW; Miyashiro JM; Russell MA; Askonas LJ; Gierse JK; Harding EI; Highkin MK; Kachur JF; Kim SH; Villani-Price D; Pyla EY; Ghoreishi-Haack NS; Smith WG
Bioorg Med Chem Lett; 2003 Mar; 13(6):1137-9. PubMed ID: 12643929
[TBL] [Abstract][Full Text] [Related]
13. Thermodynamic properties of leukotriene A
Wittmann SK; Kalinowsky L; Kramer JS; Bloecher R; Knapp S; Steinhilber D; Pogoryelov D; Proschak E; Heering J
Bioorg Med Chem; 2016 Nov; 24(21):5243-5248. PubMed ID: 27651294
[TBL] [Abstract][Full Text] [Related]
14. Discovery of novel leukotriene A4 hydrolase inhibitors based on piperidine and piperazine scaffolds.
Sandanayaka V; Mamat B; Bhagat N; Bedell L; Halldorsdottir G; Sigthorsdottir H; Andrésson T; Kiselyov A; Gurney M; Singh J
Bioorg Med Chem Lett; 2010 May; 20(9):2851-4. PubMed ID: 20371179
[TBL] [Abstract][Full Text] [Related]
15. Reciprocal regulation of LTA(4) hydrolase expression in human monocytes by gamma-interferon and interleukins 4 and 13: potential relevance to leukotriene regulation in glomerular disease.
Montero A; Nassar GM; Uda S; Munger KA; Badr KF
Exp Nephrol; 2000; 8(4-5):258-65. PubMed ID: 10940725
[TBL] [Abstract][Full Text] [Related]
16. Isolation and structure of leukotriene-A4 hydrolase inhibitor: 8(S)-amino-2(R)-methyl-7-oxononanoic acid produced by Streptomyces diastaticus.
Parnas BL; Durley RC; Rhoden EE; Kilpatrick BF; Makkar N; Thomas KE; Smith WG; Corley DG
J Nat Prod; 1996 Oct; 59(10):962-4. PubMed ID: 8904845
[TBL] [Abstract][Full Text] [Related]
17. Leukotriene A(4)-hydrolase expression and leukotriene B(4) levels in chronic inflammation of bacterial origin: immunohistochemistry and reverse-phase high-performance liquid chromatography analysis of oral mucosal epithelium.
Eberhard J; Jepsen S; Tiemann M; Krause R; Açil Y; Albers HK
Virchows Arch; 2002 Jun; 440(6):627-34. PubMed ID: 12070603
[TBL] [Abstract][Full Text] [Related]
18. Resveratrol, a red wine polyphenol, suppresses pancreatic cancer by inhibiting leukotriene A₄hydrolase.
Oi N; Jeong CH; Nadas J; Cho YY; Pugliese A; Bode AM; Dong Z
Cancer Res; 2010 Dec; 70(23):9755-64. PubMed ID: 20952510
[TBL] [Abstract][Full Text] [Related]
19. Inhibitors of leukotriene A4 (LTA4) hydrolase as potential anti-inflammatory agents.
Penning TD
Curr Pharm Des; 2001 Feb; 7(3):163-79. PubMed ID: 11311111
[TBL] [Abstract][Full Text] [Related]
20. Development of a homogeneous time-resolved fluorescence leukotriene B4 assay for determining the activity of leukotriene A4 hydrolase.
Liang AM; Claret E; Ouled-Diaf J; Jean A; Vogel D; Light DR; Jones SW; Guilford WJ; Parkinson JF; Snider RM
J Biomol Screen; 2007 Jun; 12(4):536-45. PubMed ID: 17384330
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
